Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence
RISUS_AI
2 other identifiers
observational
522
1 country
1
Brief Summary
Kidney stone disease causes significant morbidity, and stones obstructing the ureter can have serious consequences. Imaging diagnostics with computed tomography (CT) are crucial for diagnosis, treatment selection, and follow-up. Segmentation of CT images can provide objective data on stone burden and signs of obstruction. Artificial intelligence (AI) can automate such segmentation but can also be used for the diagnosis of stone disease and obstruction. In this project, the aim is to investigate if: Manual segmentation of CT scans can provide more accurate information about kidney stone disease compared to conventional interpretation. AI segmentation yields valid results compared to manual segmentation. AI can detect ureteral stones and obstruction or predict spontaneous passage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2024
CompletedFirst Posted
Study publicly available on registry
May 14, 2024
CompletedStudy Start
First participant enrolled
May 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2028
ExpectedAugust 11, 2025
August 1, 2025
1.2 years
April 30, 2024
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Comparison of stone diameter from manual segmentation with radiology report
Stone diameter (in mm) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data)
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Comparison of AI-segmentation of stones (DICE-score) with manual segmentation
DICE-score for AI-segmentation of stones, compared to manual segmenation (gold standard)
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Prospective performance (diagnostic accuracy) of AI detection of ureteral stone (compared to radiology report (gold standard)
Comparison of differences in dicotomous proportions in paired data according to Newcombe
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Outcomes (11)
Comparison of stone density from manual segmentation with radiology report
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Comparison of distention of renal pelvis from manual segmentation with radiology report
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Comparison of AI-segmentation of stones (Hausdorff distance) with manual segmentation
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Comparison of AI-segmentation of stones (diagnostic accuracy) with manual segmentation
At time of CT examination (inclusion and follow up - expected average 12 weeks)
Comparison of AI-segmentation of renal pelvis (Dice-score) with manual segmentation
At time of CT examination (inclusion and follow up - expected average 12 weeks)
- +6 more secondary outcomes
Study Arms (1)
Adults investigated with CT for suspected urinary stone disease
Newly occurring colic pain and clinical suspicion of kidney stones or known kidney stone with new/increasing symptoms. Age ≥ 18 years
Eligibility Criteria
Patients referred for CT for new/acute episode of renal colic and suspicion of /or known urinary stone disease.
You may qualify if:
- Referral for CT due to episode of renal colic and clinical suspicion of urinary stone disease or
- Referral for CT due to new episode of pain in patient with known urinary stone disease
- Age ≥ 18 years
You may not qualify if:
- Referral for control CT of asymptomatic patients with known urinary stone disease
- Referral for control CT after treatment
- Referral for control CT for spontaneous passage of stone.
- Lack of informed consent for any reason.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oslo University Hospital, Aker
Oslo, 0586, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter M. Lauritzen, MD, PhD
Oslo University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 30, 2024
First Posted
May 14, 2024
Study Start
May 21, 2024
Primary Completion
August 2, 2025
Study Completion (Estimated)
March 28, 2028
Last Updated
August 11, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share